Halberd Corp (OTC: HALB) Announces Breakthrough in Candida Auris Treatment
Halberd Corporation (OTC: HALB) a leading provider of innovative healthcare solutions, announces a breakthrough in the development of a treatment for Candida Auris infections. Halberd Demonstrates Eradication of Candida Auris Fungus in 5 minutes at Youngstown State University (YSU). Candida Auris is one of the antibiotic resistant infectious pathogens sent by the CDC (Centers for Disease Control and Prevention) to Youngstown State University (YSU) for testing. Trading Activity The stock…